Memantine, a non-competitive NMDA receptor antagonist, is used to treat Alzheimer's disease. Therefore, loading memantine in nanoparticles (NPs) could be an essential tool to improve the treatment effectiveness while reducing drug toxicity. Even though some approaches have been described to quantify memantine, none reported optimized methods using high-performance liquid chromatography resorting to ultraviolet ...
This work assessed firefighters exposure to gases pollutants in non- fire work settings during the pre-fire season as a baseline for the respective occupational exposure characterization. Indoor air sampling (total volatile organic compoundsTVOCs, ozone-O3, and carbon di oxide-CO2) was conducted for two weeks in the pre-fire season of 2021 in seven firehouses (FH1FH7) situated in the north-interior of Portugal....
Alzheimer's disease (AD) is an incurable neurological illness and the leading cause of dementia, characterized by amyloid β (Aβ) fibril deposits. Caffeic acid (CA) has demonstrated potential value for AD therapy due to its antiamyloidogenic, anti-inflammatory, and antioxidant properties. However, its chemical instability and limited bioavailability limit its therapeutic potential in vivo. Herein, liposomes load...